Variables | RFS | OS | ||
---|---|---|---|---|
RR (95% CI) | P value | RR (95% CI) | P value | |
For general | Ā | Ā | Ā | Ā |
āHistological type | 1.32 (0.82-2.12) | 0.248 | 1.71 (0.91-3.21) | 0.098 |
āAge (years)āā¤ā50 | 1.23 (0.94-1.59) | 0.131 | 1.43 (0.75-2.73) | 0.284 |
āTumor size (cm) >2 | 1.47 (0.90-2.31) | 0.124 | 1.71 (0.73-4.00) | 0.215 |
āNodes positive | 1.61 (1.37-1.88) | <0.001 | 1.40 (1.08-1.81) | 0.012 |
āHigher TNM stage | 1.56 (1.01-2.24) | 0.016 | 1.78 (1.03-3.07) | 0.039 |
āER positive | 0.62 (0.43-0.91) | 0.016 | 0.55 (0.31-1.00) | 0.065 |
āPR positive | 0.59 (0.40-0.89) | 0.011 | 0.51 (0.28-0.94) | 0.031 |
āHR positive | 0.54 (0.32-0.91) | 0.022 | 0.46 (0.21-1.02) | 0.054 |
āHER2/neu positive | 1.21 (0.93-1.58) | 0.157 | 1.24 (0.83-1.85) | 0.304 |
āChemotherapy | 0.57 (0.32-1.03) | 0.060 | 0.57 (0.24-1.35) | 0.200 |
āRadiotherapy | 0.54 (0.40-0.75) | <0.001 | 1.21 (0.74-2.02) | 0.414 |
āHormonotherapy | 0.68 (0.51-0.90) | 0.008 | 0.73 (0.47-1.13) | 0.159 |
For ILC | Ā | Ā | Ā | Ā |
āAge (years)āā¤ā50 | 5.72 (0.83-39.32) | 0.076 | 0.92 (0.81-1.04) | 0.182 |
āTumor size (cm) >2 | 2.51 (0.61-10.41) | 0.204 | 2.21 (0.97-5.01) | 0.058 |
āNodes positive | 2.87 (1.06-7.69) | 0.038 | 5.55 (0.93-33.33) | 0.060 |
āHigher TNM stage | 4.79 (2.79-11.85) | 0.002 | 3.31 (2.15-9.45) | 0.006 |
āER positive | 1.04 (0.175-6.21) | 0.964 | 1.98 (0.15-25.38) | 0.600 |
āPR positive | 0.52 (0.10-2.58) | 0.420 | 0.28 (0.02-3.24) | 0.308 |
āHR positive | 0.66 (0.05-9.24) | 0.760 | 0.39 (0.01-20.20) | 0.643 |
āHER2/neu positive | 1.45 (0.41-5.18) | 0.569 | 0.85 (0.21-3.42) | 0.822 |
āChemotherapy | 0.29 (0.02-4.73) | 0.383 | 0.32 (0.12-1.05) | 0.060 |
āRadiotherapy | 0.86 (0.27-2.78) | 0.809 | 1.22 (0.26-5.72) | 0.796 |
āHormonotherapy | 1.38 (0.42-4.54) | 0.595 | 0.90 (0.21-3.76) | 0.889 |
For IDC | Ā | Ā | Ā | Ā |
āAge (years)āā¤ā50 | 1.21 (0.92-1.59) | 0.186 | 1.55 (1.00-2.34) | 0.049 |
āTumor size (cm) >2 | 1.39 (0.84-2.32) | 0.201 | 2.34 (0.84-6.55) | 0.105 |
āNodes positive | 1.62 (1.37-1.91) | <0.001 | 1.66 (1.27-2.17) | <0.001 |
āHigher TNM stage | 1.52 (1.03-2.23) | 0.056 | 1.93 (1.07-3.48) | 0.029 |
āER positive | 0.62 (0.42-0.93) | 0.021 | 0.51 (0.27-0.97) | 0.040 |
āPR positive | 0.60 (0.39-0.91) | 0.016 | 0.47 (0.25-0.91) | 0.025 |
āHR positive | 0.53 (0.31-0.92) | 0.023 | 0.38 (0.16-0.88) | 0.025 |
āHER2/neu positive | 1.19 (0.91-1.57) | 0.206 | 1.26 (0.82-1.94) | 0.292 |
āChemotherapy | 0.60 (0.33-1.10) | 0.099 | 0.82 (0.33-2.03) | 0.662 |
āRadiotherapy | 0.51 (0.38-0.69) | <0.001 | 0.47 (0.30-0.75) | 0.002 |
āHormonotherapy | 0.64 (0.47-0.86) | 0.004 | 0.67 (0.42-1.08) | 0.101 |